Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Pål Nyrén, Fahim Amini, Gerald Möller, David Walt, Robert Epstein

Premium

Pål Nyrén was named one of the European Patent Office's Inventors of the Year for his development of DNA pyrosequencing technology. Nyrén was one of five winners of the 2013 European Inventor Award, from a group of 15 total nominees from 11 countries. He is currently a professor of biochemistry at the KTH Royal Institute of Technology in the Netherlands. Previously, he founded the company Biotage and was an associate professor of biochemistry at the University of Stockholm. He holds a PhD from the University of Stockholm.


BioNano Genomics has named Fahim Amini vice president of commercial operations in Europe, Middle East, and Africa. He will be responsible for expanding BioNano's commercial reach of the Irys System. Most recently, Amini was director of Europe, Middle East, and Africa at Complete Genomics. He has also held commercial roles at Illumina and Affymetrix.


Illumina has elected Gerald Möller and David Walt to its board of directors for a three-year term until its annual meeting of stockholders in 2016. The firm has also elected Robert Epstein to its board for one year, until the annual meeting of stockholders in 2014.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.